News: genetic testing, healthcare in the UK, drug trials
A few stories from Medical News Today over the last couple of weeks:
- "FDA To Begin Requiring Approval Before Genetic Tests Can Be Marketed" and "Claiming Diagnostic Tests For Diabetes Genes Is Misleading, Say Experts, UK" (related to this past post)
- "Put Clinical Evidence Before Cost, Says BMA, U.K." - quoting Dr. Sam Everington from the British Medical Association regarding the new initiative from the UK's National Institute for Health and Clinical Excellence (NICE) to identify ineffective healthcare interventions - "we would not want to see a blanket ban imposed on certain treatments since there may be occasions where individual patients, with specific health needs, would necessitate a particular intervention. Decisions taken by NICE must therefore allow for such treatments to be available for patients whose health outcomes would improve."
- "Five Lawmakers Call For GAO Investigation Into Clinical Trials Comparing New Drugs With Those Already On Market"
Labels: clinical trials, diabetes, drugs, evidence-based medicine, genetic testing
0 Comments:
Post a Comment
<< Home